SEC Comment Letter 0000000000-23-001030 to 89bio, Inc. (ETNB) (CIK 0001785173)
89bio, Inc. (ETNB) (CIK 0001785173)
Date: Feb. 1, 2023 · CIK: 0001785173 · Accession: 0000000000-23-001030
AI Filing Summary & Sentiment
File numbers found in text: 333-269471
Letter
United States securities and exchange commission logo February 1, 2023 Rohan Palekar Chief Executive Officer 89bio, Inc. 142 Sansome Street, 2nd Floor San Francisco, CA 94104 Re:89bio, Inc. Registration Statement on Form S-3 Filed January 31, 2023 File No. 333-269471 Dear Rohan Palekar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Branden Berns
Show Raw Text
United States securities and exchange commission logo
February 1, 2023
Rohan Palekar
Chief Executive Officer
89bio, Inc.
142 Sansome Street, 2nd Floor
San Francisco, CA 94104
Re:89bio, Inc.
Registration Statement on Form S-3
Filed January 31, 2023
File No. 333-269471
Dear Rohan Palekar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Branden Berns